BioVenture VoiCes with Chris Garabedian cover image

Episode 33: Pappas Capital's Art Pappas

BioVenture VoiCes with Chris Garabedian

00:00

Notable Exits and Approved Products

Art highlights successes including PARP inhibitors, migraine therapy development, and rare disease deals.

Play episode from 46:10
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app